Megan N. Stack, NP
- Instructor of Medicine, Division of Nephrology and Hypertension, School of Medicine
Biography
Megan Stack is a Board Certified Family Nurse Practitioner through the American Nurses Credentialing Center. Megan has extensive experience in chronic kidney disease and transplant nephrology. Prior to joining Oregon Health & Science University in 2017, Megan worked for a private nephrology practice as a Family Nurse Practitioner focused on out-patient dialysis, chronic kidney disease, and dialysis access management from 2012-2017. Before relocating to Portland, Oregon in 2012, Megan worked in the New York Presbyterian Weill-Cornell Medical transplant program during 2006-2012, as a clinical transplant coordinator from 2010-2012 and as a Registered Nurse from 2006-2010. Before her career in nephrology, Megan worked in psychology from 2000-2005. Megan received her Bachelor's of Science and Master’s of Science degrees in Nursing from Pace University, as well as a Bachelor's of Arts in Psychology from Fordham University.
Education and training
-
Degrees
- B.A., 2000, Fordham University
- B.S.N., 2006, Pace University
- M.S.N., 2011, Pace University
-
Certifications
- American Nurses Credentialing Center
- American Board for Transplant Certification
Memberships and associations:
- American Nephrology Nursing Association
- North American Transplant Coordinators Association
Publications
Selected publications
- Gilbert, A, Scott, D, Stack, M de Mattos, M , Norman, D, Rehman, S, Lockridge, J, Woodland, D, Kung, V and Andeen, N Long-standing donor diabetes and pathologic findings are associated with shorter allograft survival in recipients of kidney transplants from diabetic donors. Modern Pathology 28-September-2021 https://doi.org/10.1038/s41379-021-00927-2
- Kavanagh C, R, Zanoni F, Leal R, Jain N, G, Stack M, N, Vasilescu E, -R, Serban G, Shaut C, Kamal J, Kudose S, Martinho A, Alves R, Santoriello D, Canetta P, A, Cohen D, Radhakrishnan J, Appel G, B, Stokes M, B, Markowitz G, S, D’Agati V, D, Kiryluk K, Andeen N, K, Batal I: Clinical Predictors and Prognosis of Recurrent IgA Nephropathy in the Kidney Allograft . Glomerular Dis 2021. doi: 10.1159/000519834
- Lockridge J, Pryor J, Stack, M, Rehman, Shehzad, Norman D, DeMattos Angelo, Olyaei Ali, New Onset Diabetes After Kidney Transplantation in Asian Americans – Is There An Increased Risk?: New Onset Diabetes after Transplantation, Transplantation Reports,2021, https://doi.org/10.1016/j.tpr.2021.100080.
- Lockridge J, Roberts D, Olyaei A, Noble BN, Langewisch E, Rehman S, Stack M, Scott D, Orloff S, Shaut C, Gardner B, Bennett W, Norman D. Cytomegalovirus serologic matching in deceased donor kidney allocation optimizes high- and low-risk (D+R- and D-R-) profiles and does not adversely affect transplant rates. Am J Transplant. 2020 Dec;20(12):3502-3508. doi: 10.1111/ajt.15976. Epub 2020 Jun 23. PMID: 32372499.
- Rehman S, de Mattos A, Stack M, Norman D, Zapata S, Wang P, Mansoor A.H., Kung V. Sustained response to eculizumab in a patient with COVID-19 associated with acute thrombotic microangiopathy of the allograft kidney: A Case Report
- Kavanagh C, Zanoni F, Leal R, Jain N, Stack M, Vasilescu E-R, Serban G, Shaut C, Kamal J, Kudose S, Martinho A, Alves R, Santoriello D, Canetta P, Cohen D, Radhakrishnan J, APpel G, Stokes M, Markowitz G, D'Agati V, Kiryluk K, Andeen N, Batal I. Clinical Predictors and Prognosis of Recurrent IgA Nephropathy in the Kidney Allograft.
- Gilbert A, Scott S, Stack M, de Mattos A, Norman D, Rehman S, Lockridge J, Woodland D, Kung V, Andeen N. Long-standing donor diabetes and pathologic findings are associated with shorter allograft survival in recipients of kidney transplants from diabetic donors.
- Lockridge J, Pryor J, Stack M, Rehman S, Norman D, de Mattos A, Olyaei A New onset diabetes after kidney transplantation in Asian Americans - Is there an increased risk?
- Lockridge J, Roberts D, Olyaei A, Noble B, Langewisch E, Rehman S, Stack M, Scott D, Orloff S, Shaut C, Gardner B, Bennet W, Norman D. Cytomegalovirus serologic matching in deceased donor kidney allocation optimized high- and low-risk (D+R- and D-R-) profiles and does not adversely affect transplant rates.